Correlation Between Crescita Therapeutics and Canntab Therapeutics
Can any of the company-specific risk be diversified away by investing in both Crescita Therapeutics and Canntab Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crescita Therapeutics and Canntab Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crescita Therapeutics and Canntab Therapeutics Limited, you can compare the effects of market volatilities on Crescita Therapeutics and Canntab Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crescita Therapeutics with a short position of Canntab Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crescita Therapeutics and Canntab Therapeutics.
Diversification Opportunities for Crescita Therapeutics and Canntab Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Crescita and Canntab is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Crescita Therapeutics and Canntab Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Canntab Therapeutics and Crescita Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crescita Therapeutics are associated (or correlated) with Canntab Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Canntab Therapeutics has no effect on the direction of Crescita Therapeutics i.e., Crescita Therapeutics and Canntab Therapeutics go up and down completely randomly.
Pair Corralation between Crescita Therapeutics and Canntab Therapeutics
Assuming the 90 days horizon Crescita Therapeutics is expected to generate 1.76 times more return on investment than Canntab Therapeutics. However, Crescita Therapeutics is 1.76 times more volatile than Canntab Therapeutics Limited. It trades about 0.05 of its potential returns per unit of risk. Canntab Therapeutics Limited is currently generating about 0.04 per unit of risk. If you would invest 56.00 in Crescita Therapeutics on November 2, 2024 and sell it today you would lose (17.00) from holding Crescita Therapeutics or give up 30.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.4% |
| Values | Daily Returns |
Crescita Therapeutics vs. Canntab Therapeutics Limited
Performance |
| Timeline |
| Crescita Therapeutics |
| Canntab Therapeutics |
Crescita Therapeutics and Canntab Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Crescita Therapeutics and Canntab Therapeutics
The main advantage of trading using opposite Crescita Therapeutics and Canntab Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crescita Therapeutics position performs unexpectedly, Canntab Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Canntab Therapeutics will offset losses from the drop in Canntab Therapeutics' long position.| Crescita Therapeutics vs. Amexdrug | Crescita Therapeutics vs. The BC Bud | Crescita Therapeutics vs. Cannara Biotech | Crescita Therapeutics vs. Knight Therapeutics |
| Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. HLS Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |